Emerging biomarkers and molecular targets for precision medicine in cervical cancer.
Biochim Biophys Acta Rev Cancer
; 1879(3): 189106, 2024 May.
Article
en En
| MEDLINE
| ID: mdl-38701936
ABSTRACT
Cervical cancer remains a significant global health burden, necessitating innovative approaches for improved diagnostics and personalized treatment strategies. Precision medicine has emerged as a promising paradigm, leveraging biomarkers and molecular targets to tailor therapy to individual patients. This review explores the landscape of emerging biomarkers and molecular targets in cervical cancer, highlighting their potential implications for precision medicine. By integrating these biomarkers into comprehensive diagnostic algorithms, clinicians can identify high-risk patients at an earlier stage, enabling timely intervention and improved patient outcomes. Furthermore, the identification of specific molecular targets has paved the way for the development of targeted therapies aimed at disrupting key pathways implicated in cervical carcinogenesis. In conclusion, the evolving landscape of biomarkers and molecular targets presents exciting opportunities for advancing precision medicine in cervical cancer. By harnessing these insights, clinicians can optimize treatment selection, enhance patient outcomes, and ultimately transform the management of this devastating disease.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Biomarcadores de Tumor
/
Neoplasias del Cuello Uterino
/
Medicina de Precisión
/
Terapia Molecular Dirigida
Límite:
Female
/
Humans
Idioma:
En
Revista:
Biochim Biophys Acta Rev Cancer
/
Biochim. biophys. acta, Rev. cancer (Online)
/
Biochimica et biophysica acta. Reviews on cancer (Online)
Año:
2024
Tipo del documento:
Article
País de afiliación:
India